Connection

Robert Fowler to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Robert Fowler has written about Antibodies, Monoclonal, Humanized.
Robert Fowler
Connection Strength
0.047
Antibodies, Monoclonal, Humanized
  1. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 05; 9(5):522-532.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.